Shaping the Future of Access Through Science and Policy
Why Attend
This is...
07:00, Sunday, 8 Nov 2026 + 3 more
07:00, Monday, 9 Nov 2026
07:00, Tuesday, 10 Nov 2026
07:00, Wednesday, 11 Nov 2026
FACILITATE LIVE is very pleased to welcome you to our upcoming PATIENT ACCESS World Congress 2025 Europe. The two-day Congress aims to build meaningful collaborations within the industry, advocacy groups, clinicians, researchers and most importantly, patients and their caregivers.
The congress focuses on “Improving Patient Access for Better Health Outcomes and Quality of Life.”
Massive investment and advances in research and development of novel therapeutics by Pharmaceutical and Biotechnology manufacturers, has resulted in the life science industry obtaining an accelerated rise in the number of drugs that have been brought to market over the past decade.
Patient access in pharma and healthcare refers to ensuring that patients can readily obtain the necessary medications and treatments they need in a timely and affordable manner. This involves a range of activities, including negotiating pricing agreements, demonstrating the clinical and economic value of treatments, and addressing barriers to access.
Patient access also refers to the convenience with which patients can obtain medical care. This encompasses everything from appointment scheduling to health record access. This idea is evolving rapidly in the digital age. Technology is a key factor in improving efficiency and effectiveness.
Patient access is really about making sure that patients can easily get the medications and treatments they need when they need them, and at a price they can afford. This involves a lot of different things, from working out pricing agreements to showing how valuable treatments are from both a clinical and economic perspective, and also tackling anything that might stand in the way of access.
Here are some key things to keep in mind: Patient Access Schemes (PASs), which are those confidential pricing deals that help make expensive drugs more affordable, and Market Access, which is pretty much the same as patient access and includes all the strategies companies use to make sure patients can get their products. It also includes negotiating with healthcare, payers and providers to set prices and coverage, demonstrating the clinical and economic benefits of products to justify their prices, addressing barriers like financial constraints or lack of awareness, focusing on patient involvement in decisions, and recognizing that patient access is always changing with new technologies and treatments.
There are indeed several challenges such as the high costs of drugs, payer strategies that limit access, geographical barriers, regulatory hurdles, and a general lack of awareness among some patients. To combat this, companies can implement discounts, patient assistance programs, innovative pricing agreements, and digital tools.
In conclusion, patient access is complex. It needs pharmaceutical companies, healthcare providers, payers, and patients to all work together so that everyone can get the care they need.
07:00, Sunday, 8 Nov 2026 + 3 more
07:00, Monday, 9 Nov 2026
07:00, Tuesday, 10 Nov 2026
07:00, Wednesday, 11 Nov 2026
07:45, Monday, 9 Nov 2026 + 2 more
07:45, Tuesday, 10 Nov 2026
07:45, Wednesday, 11 Nov 2026
08:00, Monday, 9 Nov 2026 + 1 more
08:00, Tuesday, 10 Nov 2026
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Reading this content is completely free
Already have an account? Sign in